Thus, the inhibition of IL-8 and the promotion of IL-10 synthesis possess important clinical significance with regard to the control of airway inflammation in COPD and the improvement of the condition and lung function of the patients. The gene discussed is CXCL8; the disease is chronic obstructive pulmonary disease.